{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:13:34Z","timestamp":1793092414736,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus University","doi-asserted-by":"publisher","award":["25051018"],"award-info":[{"award-number":["25051018"]}],"id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008368","name":"Arthritis Society","doi-asserted-by":"publisher","award":["R224-A8313"],"award-info":[{"award-number":["R224-A8313"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["L-2023-00094"],"award-info":[{"award-number":["L-2023-00094"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semarthrit.2025.152707","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:17:40Z","timestamp":1741303060000},"page":"152707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Molecular mechanisms underlying thrombosis in systemic lupus erythematosus \u2013 A Systematic review"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8670-0750","authenticated-orcid":false,"given":"Mads L","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Z","family":"Langkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Troldborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152707_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/keab362","article-title":"All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study","volume":"61","author":"Moghaddam","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","article-title":"Mortality and causes of death in systemic lupus erythematosus over the last decade: data from a large population-based study","volume":"112","author":"Zen","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12959-015-0043-3","article-title":"Systemic lupus erythematosus and thrombosis","volume":"13","author":"Bazzan","year":"2015","journal-title":"Thromb J"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40744-022-00513-1","article-title":"Systematic literature review and meta-analysis of venous thromboembolism events in systemic lupus erythematosus","volume":"10","author":"Bello","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0006","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/428269","article-title":"Thrombosis in systemic lupus erythematosus: a review article","volume":"2012","author":"Al-Homood","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0007","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.21314","article-title":"Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus","volume":"53","author":"Sarabi","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0008","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0009","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/key307","article-title":"Under crossfire: thromboembolic risk in systemic lupus erythematosus","volume":"58","author":"Ramirez","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152707_bib0010","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/art.21149","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients","volume":"52","author":"Calvo-Al\u00e9n","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0011","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.150506","article-title":"Venous and arterial thrombotic events in systemic lupus erythematosus","volume":"43","author":"Hinojosa-Azaola","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0013","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.berh.2017.09.008","article-title":"Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"de Groot","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"14","key":"10.1016\/j.semarthrit.2025.152707_bib0015","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/bph.15476","article-title":"Complement, inflammation and thrombosis","volume":"178","author":"Rawish","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0016","first-page":"E155","article-title":"Platelets and the lectin pathway of complement activation in patients with systemic lupus erythematosus or antiphospholipid syndrome","volume":"7","author":"Vils","year":"2022","journal-title":"TH Open"},{"issue":"13","key":"10.1016\/j.semarthrit.2025.152707_bib0017","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/0961203312457210","article-title":"Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus\u2013a possible link to venous thrombosis?","volume":"21","author":"Lood","year":"2012","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0018","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jth.13208","article-title":"The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation","volume":"14","author":"Kozarcanin","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0019","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/ATVBAHA.116.308126","article-title":"Activated Platelets induce endothelial cell activation via an interleukin-1\u03b2 pathway in systemic lupus erythematosus","volume":"37","author":"Nhek","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0020","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s10067-018-4104-4","article-title":"Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients","volume":"37","author":"Buga\u0142a","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0021","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/rheumatology\/keaa092","article-title":"Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus","volume":"59","author":"Svenungsson","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0022","doi-asserted-by":"crossref","first-page":"e99386","DOI":"10.1371\/journal.pone.0099386","article-title":"Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus","volume":"9","author":"Lood","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0023","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0024","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","author":"Fanouriakis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0025","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0026","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol,"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0027","unstructured":"Wells, G.A., et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"key":"10.1016\/j.semarthrit.2025.152707_bib0028","article-title":"Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: the QUIN","author":"Sheth","year":"2022","journal-title":"J Prosthet Dent"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"13","key":"10.1016\/j.semarthrit.2025.152707_bib0031","first-page":"23","article-title":"Chronic Immune Platelet Activation Is Followed by Platelet Refractoriness and Impaired Contractility","author":"Andrianova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0032","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20171510","article-title":"Impaired contraction of blood clots as a novel prothrombotic mechanism in systemic lupus erythematosus","volume":"132","author":"Le Minh","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"25","key":"10.1016\/j.semarthrit.2025.152707_bib0033","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood.2020004974","article-title":"FcgRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus","volume":"136","author":"Melki","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102355","article-title":"In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation","volume":"107","author":"Andrianova","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2019.07.006","article-title":"aCL\/\u03b22GPI and aPS\/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-\u03b1 secretion by mononuclear cells","volume":"181","author":"Kaneshige","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0036","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2019.07.006","article-title":"aCL\/\u03b2(2)GPI and aPS\/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-\u03b1 secretion by mononuclear cells","volume":"181","author":"Kaneshige","year":"2019","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0037","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajpath.2012.09.005","article-title":"Fc\u03b3RIIa ligation induces platelet hypersensitivity to thrombotic stimuli","volume":"182","author":"Berlacher","year":"2013","journal-title":"Am J Pathol"},{"issue":"16","key":"10.1016\/j.semarthrit.2025.152707_bib0038","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","article-title":"Autoantibodies specific to a peptide of \u03b22-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes","volume":"120","author":"Colasanti","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0039","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/CH-2011-1409","article-title":"Erythrocyte aggregation in patients with systemic lupus erythematosus","volume":"47","author":"Spengler","year":"2011","journal-title":"Clin Hemorheol Microcirc"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0040","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1002\/art.30525","article-title":"Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis","volume":"63","author":"Lambrianides","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0041","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3899\/jrheum.091420","article-title":"Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus","volume":"37","author":"Suzuki","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2007.10.173","article-title":"Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients","volume":"365","author":"Nojima","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0043","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10067-007-0673-3","article-title":"IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis","volume":"27","author":"Bu","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0044","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2006-10-053199","article-title":"\u03b22-Glycoprotein I inhibits vonWillebrand factor-dependent platelet adhesion and aggregation","volume":"110","author":"Hulstein","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0045","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0046","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","article-title":"Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome","volume":"107","author":"Cesarman-Maus","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0047","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.ATV.0000150415.18759.36","article-title":"Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus","volume":"25","author":"Cederholm","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0048","first-page":"1303","article-title":"Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus","volume":"92","author":"Vlachoyiannopoulos","year":"2004","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0049","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1160\/TH03-07-0487","article-title":"Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome","volume":"91","author":"Dignat-George","year":"2004","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0050","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/art.20564","article-title":"Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients","volume":"50","author":"Dieud\u00e9","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0051","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1191\/0961203302lu256oa","article-title":"Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus","volume":"11","author":"Mu\u00f1oz-Rodr\u00edguez","year":"2002","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0052","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.4049\/jimmunol.168.8.4209","article-title":"Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells","volume":"168","author":"Cho","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0053","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0049-3848(01)00315-2","article-title":"Thromboagglutination by anticardiolipin antibody complex in the antiphospholipid syndrome - A possible mechanism of immune-mediated thrombosis","volume":"103","author":"Wiener","year":"2001","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0054","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2141.2001.03101.x","article-title":"Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis","volume":"115","author":"Joseph","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0056","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI119889","article-title":"Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset","volume":"101","author":"Nakamura","year":"1998","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0057","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ajh.2830370104","article-title":"Disturbances in the tissue plasminogen activator\/plasminogen activator inhibitor (TPA\/PAI) system in systemic lupus erythematosus","volume":"37","author":"Ruiz-Arguelles","year":"1991","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0058","first-page":"247","article-title":"Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus","volume":"74","author":"Vismara","year":"1988","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0059","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH05-05-0310","article-title":"Circulating platelet-derived microparticles in systemic lupus erythematosus. association with increased thrombin generation and procoagulant state","volume":"95","author":"Pereira","year":"2006","journal-title":"Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0060","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0061","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus\u2013possible association with thrombotic and thrombocytopenic complications","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0062","first-page":"1303","article-title":"Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus","volume":"92","author":"Vlachoyiannopoulos","year":"2004","journal-title":"Thromb Haemostasis"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152707_bib0063","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"51","key":"10.1016\/j.semarthrit.2025.152707_bib0064","doi-asserted-by":"crossref","first-page":"16998","DOI":"10.1021\/bi051469f","article-title":"Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface","volume":"44","author":"Majumder","year":"2005","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0065","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res,"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0066","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0067","first-page":"1780","article-title":"Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus","volume":"33","author":"Chang","year":"2006","journal-title":"J Rheumatol"},{"issue":"6399","key":"10.1016\/j.semarthrit.2025.152707_bib0068","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6398","key":"10.1016\/j.semarthrit.2025.152707_bib0069","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/bmj.287.6398.1021","article-title":"Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant","volume":"287","author":"Boey","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of \u03b22-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"Jankowski","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0071","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2010-07-299099","article-title":"Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome","volume":"117","author":"Romay-Penabad","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152707_bib0072","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0073","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajpath.2012.09.005","article-title":"Fc\u03b3RIIa ligation induces platelet hypersensitivity to thrombotic stimuli","volume":"182","author":"Berlacher","year":"2013","journal-title":"Am J Pathol"},{"issue":"20","key":"10.1016\/j.semarthrit.2025.152707_bib0074","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.117.032790","article-title":"B cell\u2013activating factor neutralization aggravates atherosclerosis","volume":"138","author":"Tsiantoulas","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152707_bib0075","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","article-title":"Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis","volume":"185","author":"Kyaw","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0076","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/1744666X.2014.857602","article-title":"Understanding the role of B cells in atherosclerosis: potential clinical implications","volume":"10","author":"Morris-Rosenfeld","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0077","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0961203317713143","article-title":"Comparative efficacy and safety of intravenous or subcutaneous belimumab in combination with standard therapy in patients with active systemic lupus erythematosus: a Bayesian network meta-analysis of randomized controlled trials","volume":"27","author":"Lee","year":"2018","journal-title":"Lupus"},{"issue":"8500","key":"10.1016\/j.semarthrit.2025.152707_bib0078","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0079","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1537-2995.2012.03589.x","article-title":"Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010","volume":"52","author":"Daniel","year":"2012","journal-title":"Transfusion (Paris)"},{"issue":"Suppl 1(Suppl 1)","key":"10.1016\/j.semarthrit.2025.152707_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/cei.12518","article-title":"Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis","volume":"178","author":"Bonilla","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0081","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1423-0410.2011.01502.x","article-title":"Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products","volume":"102","author":"Etscheid","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0082","article-title":"Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events","author":"Nikolopoulos","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0083","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0084","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/art.10273","article-title":"The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus","volume":"46","author":"Huang","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0085","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1160\/TH04-12-0774","article-title":"The role of CD40 in CD40L- and antibody-mediated platelet activation","volume":"93","author":"Langer","year":"2005","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0086","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4049\/jimmunol.0903888","article-title":"Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice","volume":"185","author":"Robles-Carrillo","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0087","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7861\/clinmedicine.17-3-220","article-title":"Developments in therapy with monoclonal antibodies and related proteins","volume":"17","author":"Shepard","year":"2017","journal-title":"Clinical Medicine"},{"issue":"20","key":"10.1016\/j.semarthrit.2025.152707_bib0088","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152707_bib0089","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/art.1780401212","article-title":"Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis","volume":"40","author":"Ekdahl","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(89)90110-2","article-title":"Dephosphorylation of human fibrinogen, previously phosphorylated in vitro by protein kinase C, by whole blood or intestinal alkaline phosphatase. Effects on thrombin-induced gelation of in vitro dephosphorylated human fibrinogen","volume":"53","author":"Forsberg","year":"1989","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0091","first-page":"408","article-title":"Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus","volume":"56","author":"Lood","year":"2017","journal-title":"Rheumatology (United Kingdom)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0092","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/ATVBAHA.110.221788","article-title":"Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease","volume":"31","author":"Slavka","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0093","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/0975-3583.102694","article-title":"Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: a case control study","volume":"3","author":"Khode","year":"2012","journal-title":"J Cardiovasc Dis Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0094","first-page":"930","article-title":"Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy","volume":"99","author":"Cesari","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2018.38","article-title":"The non-haemostatic role of platelets in systemic lupus erythematosus","volume":"14","author":"Linge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0096","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.12587","article-title":"The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity","volume":"164","author":"Xie","year":"2014","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0097","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2006.065037","article-title":"Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies","volume":"66","author":"Pierangeli","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0098","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2 glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2 glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0099","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2004.02.015","article-title":"Endothelial cell activation by antiphospholipid antibodies","volume":"112","author":"Meroni","year":"2004","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0100","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1182\/blood-2004-05-1708","article-title":"Annexin A2 mediates endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0101","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152707_bib0102","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.61.12.1065","article-title":"Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus","volume":"61","author":"Manger","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12959-015-0047-z","article-title":"Thrombosis in vasculitis: from pathogenesis to treatment","volume":"13","author":"Emmi","year":"2015","journal-title":"Thrombosis Journal"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0104","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0106","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103447","article-title":"Risk of venous thromboembolism in autoimmune diseases: a comprehensive review","volume":"22","author":"Menichelli","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0109","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2008.099051","article-title":"High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients","volume":"68","author":"Allenbach","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","article-title":"Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options","volume":"67","author":"Maclean","year":"2007","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.semarthrit.2025.152707_bib0111","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1161\/01.CIR.0000068167.08920.F1","article-title":"Cardiology patient page. Factor V Leiden","volume":"107","author":"Ornstein","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/gene.2009.32","article-title":"Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis","volume":"10","author":"Kaiser","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2019.08.009","article-title":"Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death","volume":"215","author":"Posch","year":"2020","journal-title":"Transl Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152707_bib0114","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052758","article-title":"Assessing plasmin generation in health and disease","volume":"22","author":"Miszta","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152707_bib0115","first-page":"178","article-title":"Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis","volume":"43","author":"Lisman","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0116","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood-2012-06-437772","article-title":"Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2018.08.005","article-title":"The role of neutrophils in thrombosis","volume":"170","author":"Kapoor","year":"2018","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152707_bib0118","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/art.41796","article-title":"RNA externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells","volume":"73","author":"Blanco","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0119","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"19","key":"10.1016\/j.semarthrit.2025.152707_bib0120","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.18632\/oncotarget.23206","article-title":"Coagulation cascade and complement system in systemic lupus erythematosus","volume":"9","author":"Liang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.08.007","article-title":"Antibodies and complement are key drivers of thrombosis","author":"Stark","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"eBioMedicine"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0123","first-page":"9","article-title":"Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications","author":"Tedesco","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0124","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semarthrit.2025.152707_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2018.12.008","article-title":"Correlation between active disease and hypercoagulability state in patients with systemic lupus erythematosus","volume":"490","author":"Ferreira","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0126","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0127","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/a-2178-6491","article-title":"The Concept of Thromboinflammation","volume":"44","author":"Schrottmaier","year":"2024","journal-title":"Hamostaseologie"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152707_bib0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0132","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152707_bib0133","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/asheducation-2016.1.714","article-title":"What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?","volume":"2016","author":"Wang","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0134","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0038-1650183","article-title":"The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface","volume":"45","author":"Winocour","year":"1981","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152707_bib0136","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152707_bib0137","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/rheumatology\/kew231","article-title":"Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study","volume":"55","author":"Iudici","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152707_bib0138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152707_bib0139","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152707_bib0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1191\/0961203306lu2311oa","article-title":"Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant","volume":"15","author":"Nagasawa","year":"2006","journal-title":"Lupus"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:23:59Z","timestamp":1777472639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":140,"alternative-id":["S0049017225000782"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152707","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms underlying thrombosis in systemic lupus erythematosus \u2013 A Systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152707"}}